Core Insights - Pfizer raised its full-year profit forecast for the second consecutive time, driven by robust demand for its leading heart treatment and blood thinner [1] Company Summary - Pfizer's updated profit forecast reflects strong market performance and increased sales of its key pharmaceutical products [1]